Bayer AG will install a new chief executive on 1 June as it looks to expand its business across the agricultural, pharmaceuticals and consumer health sectors. The new CEO, Bill Anderson, is a former Roche executive with experience in the development and commercialisation of new medicines. He will take up the position on 1 June, succeeding Werner Baumann who has been with Bayer for 35 years.
